The sensor is connected to a small electronic backpack.
"When the affected person is asleep, the tumor awakens."
"Our discovery offers hope."
Caroline will be in remission for five years and will be monitored every three months by her oncologist.
By Danny Halpin via SWNS Lung cancer patients who took an experimental combination of drugs lived three months longer on average than those on standard medication,...
Results were so encouraging clinical trials are expected to begin in the next few months.
The white stuff contains chemicals that can carry siRNA's (small interfering RNAs) that prevent manufacture of proteins that fuel tumor's growth.
The international team found intermittent dosing could be a valid strategy that combines sustained anti-tumor immunity with reduced toxicity.
While the scientists have found the 58 new mutational signatures, they believe these are additional causes of cancer we do not yet fully understand.
Bacteria-based immunotherapy is a growing area of interest in cancer research - with a wave of techniques being explored today.